MacKay Shields »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by MacKay Shields

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by MacKay Shields from 13F filings

Historical chart of MacKay Shields investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by MacKay Shields consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by MacKay Shields

Quarter filed Position value Share count Share price at filing
2024-03-31 $44M 45M 0.97
2023-12-31 $42M 45M 0.93
2023-09-30 $77M 83M 0.93

More positions owned by MacKay Shields

Gulfport Energy Corp Common Shares (GPOR)
Nice Note 9/1 (Principal)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Nrg Energy DBCV 2.750% 6/0 (Principal)
Microchip Technology Note 0.125%11/1 (Principal)
Biomarin Pharmaceutical Note 1.250% 5/1 (Principal)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Southwest Airls Note 1.250% 5/0 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Vail Resorts Note 1/0 (Principal)
Integer Hldgs Corp Note 2.125% 2/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)

View all positions for MacKay Shields

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1